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Abstract
Purpose The purpose of this study is to evaluate computer-
ized monitoring of speech and swallowing outcomes and its
impact on quality of life (QoL) and emotional well-being in
head and neck cancer patients in an outpatient clinic.
Methods Sixty-seven patients, treated by single or multi-
modality treatment, completed the EORTC QLQ-C30 and
QLQ-H&N35 questionnaires and the Hospital Anxiety and
Depression Scale in an outpatient clinic, using a touch
screen computer system (OncoQuest), at baseline (at time
of diagnosis) and first follow-up (1 month after end of
treatment).
Results Tumor sites included oral cavity (n012), oropharynx
(n018), hypopharynx (n08), and larynx (n029). Tumor stage
included carcinoma in situ (n03), stage I (n021), stage II (n0
7), stage III (n015), and IV (n021). No speech or swallowing
problems at baseline or follow-up were noted in 23% (speech)
and 41 % (swallowing) of patients. Twenty-one percent
(speech) and 19 % (swallowing) had problems at baseline
and returned to normal scores at follow-up, while 16 %
(speech) and 19% (swallowing) had normal scores at baseline
and developed problems at follow-up. Forty percent (speech)
and 21 % (swallowing) had persistent problems from baseline
to follow-up. At baseline, speech problems were significantly
related to tumor site and emotional distress. At baseline and
follow-up, swallowing problems were significantly related to
QoL and emotional distress. At follow-up, speech problems
were significantly related to QoL, emotional distress, and
swallowing problems.
Conclusions Monitoring speech and swallowing problems
through OncoQuest in an outpatient clinic is feasible. Many
patients report speech and swallowing problems, negatively
affecting their QoL and emotional well-being.
Keywords Head and neck cancer . E-health .
Patient-reported speech and swallowing problems .
Quality of life . Emotional well-being
Introduction
Head and neck cancer (HNC) patients often have to deal with
speech and swallowing problems before or after treatment,
negatively affecting health-related quality of life. HNC
patients may experience discomfort and functional deficits
as a result of the disease itself, such as tumor-induced pain,
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and/or problems with swallowing and speaking prior to treat-
ment. It has been estimated that 34–75 % of HNC patients
have speech or swallowing problems after treatment [1–3]. In
clinical practice, various subjective and objective measures to
evaluate posttreatment speech and swallowing outcomes are
used. Speech outcomes can be assessed by indicators of
speech production (e.g., oral function and articulation tests
and aerodynamic and acoustical analyses), perceptual speech
evaluation (e.g., intelligibility, articulation, nasality, speech
rate, and acceptability), and by subjective measures to evalu-
ate self-reported speech problems in everyday life situations
(e.g., questionnaires). Swallowing outcome measures include
objective assessment methods such as the modified barium
swallow procedure with videofluorography [4], videofluoro-
scopy combined with manometry (manofluoroscopy) [5],
fiberoptic endoscopic examination of swallowing [6], or scin-
tigraphy [7]. Other clinician-rated dysphagia assessments can
be performed by clinical swallowing evaluation (e.g., gather-
ing information on current swallowing problems, reviewing
medical history, observing signs relevant to the patient's med-
ical status, conducting an examination of speech and swallow-
ing structures, observing the patient during trial swallows, and
by recording acute and late toxicity after radiotherapy) [8].
Patient-reported speech and swallowing problems are
usually identified through questionnaires. Implementation
of patient-reported outcomes in clinical practice may be
facilitated by information technology, allowing real-time
quick and easy presentation of results to clinicians [9–11].
In our institute, a touch screen computer-assisted data col-
lection system, OncoQuest, was developed and imple-
mented in clinical practice enabling structured monitoring
of quality of life and emotional distress [12, 13].
The purpose of this explorative study is to evaluate
structured computerized monitoring of prospective patient-
reported speech and swallowing outcomes from baseline
(pretreatment) to first follow-up 1 month after treatment in
HNC patients using OncoQuest and to investigate the im-




From February 2009 to July 2010, 67 newly diagnosed
HNC patients filled out the patient-reported outcomes
through OncoQuest. The inclusion criteria were curative
treatment for primary tumors in the larynx, hypopharynx,
oral cavity, or oropharynx. Exclusion criteria were: diseases
causing cognitive dysfunction and poor understanding of
the Dutch language. Age, gender, tumor site and stage,
and treatment modality were recorded. Informed consent
was obtained from all patients. This study was approved
by the VU University medical ethics committee.
Outcome measures
Patients completed the EORTC QLQ-C30 [14] and EORTC
QLQ-H&N35 [15] and the Hospital Anxiety and Depression
Scale (HADS) [16] at the time of diagnosis and on their first
follow-up after the end of treatment. The questionnaires were
presented through OncoQuest, a touch screen computer-based
data collection system. An example of the touch screen user
interface is shown in Fig. 1. One of the outcome variables in
OncoQuest is time to complete the questionnaire: at their first
visit, it took patients on average 8.7 min to complete all 79
items, and 8.0 min at first follow-up visit, 1 month after
treatment.
The EORTC QLQ-C30 is a cancer-specific questionnaire
and comprises a global health-related quality of life
(HRQOL) scale (two items) and five functional scales:
physical functioning (five items), role functioning (two
items), emotional functioning (four items), cognitive func-
tioning (two items), and social functioning (two items).
There are three symptom scales (fatigue (three items), nau-
sea and vomiting (two items), and pain (two items)) and six
single items relating to dyspnoea, insomnia, loss of appetite,
constipation, diarrhea, and financial difficulties. The QLQ-
C30 subscale Global QOL is used in the present study.
The EORTC QLQ-H&N35 module covers specific HNC
issues and comprises seven subscales: pain (four items),
swallowing (five items), senses (two items), speech (three
items), social eating (four items), social contact (five items),
and sexuality (two items). There are ten single items cover-
ing problems with teeth, dry mouth, sticky saliva, cough,
opening the mouth wide, weight loss, weight gain, use of
nutritional supplements, feeding tubes, and pain-killers. The
Fig. 1 Example of the user interface of OncoQuest
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speech and swallowing subscales were used in the present
study.
The scores of the QLQ-C30 and of the QLQ-H&N35 are
linearly transformed to a scale of 0 to 100, with a higher
score indicating a higher (i.e., more positive) level of func-
tioning or global HRQOL, or a higher (i.e., more negative)
level of symptoms or (speech and swallowing) problems.
Presence of speech or swallowing problems was defined as
a score ≥10 on the EORTC QLQ-H&N35 speech or swal-
lowing subscale. These cutoff scores are based on a cohort
of 110 subjects from the general population of whom 95 %
scored below 10 on these two subscales (unpublished data).
The HADS is a 14-item scale with two subscales, anxiety
and depression. The total HADS score ranges from 0 to 42;
the subscales range from 0 to 21. In psycho-oncology, the
total HADS score is proven to be an accurate instrument to
identify cancer patients with depression [17, 18] and anxiety
and other psychological sequelae. In the present study, a
total HADS score of >15 was used as indicator of a high
level of distress [19, 20].
Statistical analysis
Patients were categorized regarding presence of speech
problems (yes/no) or swallowing problems (yes/no), gender,
tumor site (larynx/hypopharynx/oropharynx/oral cavity), tu-
mor stage (carcinoma in situ/I/II/III/IV), and treatment: sur-
gery/radiotherapy/chemoradiation/surgery (other than
laryngectomy) and radiotherapy/surgery (laryngectomy)
and radiotherapy/surgery and chemoradiation. Chi-square
tests were used to investigate the relation between the pres-
ence of speech or swallowing problems and gender, tumor
site (larynx/hypopharynx vs. oral/oropharynx), tumor stage
(cis/I/II vs. III/IV), and treatment modality: single modality
(surgery or radiotherapy) vs. combined modality (surgery
and radiotherapy/chemoradiation). Pearson correlation coef-
ficients were used to test associations between speech or
swallowing problems and global QOL (global QOL scale
EORTC QLQ-C30) and emotional distress (total HADS




The patient group consisted of 51 males (76 %) and 16
females (24 %). Mean age was 64 years (range 43–83). Tumor
sites included oral cavity (n012), oropharynx (n018), hypo-
pharynx (n08), and larynx (n029). Tumor stage included
carcinoma in situ (n03), stage I (n021), stage II (n07), stage
III (n015), and IV (n021). Patients were treated by surgery
(n018), radiotherapy (n023), chemoradiation (n012),
surgery (other than laryngectomy) and postoperative ra-
diotherapy (n07), laryngectomy and radiotherapy (n06),
and surgery and postoperative chemoradiation (n01; Table 1).
Regarding assessment at first follow-up visit (follow-up),
median time since the end of treatment was 1 month (SD
1.2 months).
Patient-reported speech outcome
Mean EORTC QLQ-H&N35 speech subscale score was
22.72 (SD 26.3; range 0–100) at time of diagnosis and 29.52
(SD 25.5; range 0–89) at follow-up (Table 2). No patient-
reported speech problems at baseline or follow-up were noted
in 23 % of the patients, 21 % had speech problems at baseline
and returned to normal scores at follow-up, while 16 % of the
patients had normal scores at baseline and developed prob-
lems at follow-up. Forty percent of the patients had persistent
problems from baseline to follow-up (Fig. 2). Speech reported
outcomes were not significantly related to gender, tumor
stage, or treatment modality. At baseline, speech problems
were significantly related to tumor site (χ2010.28, p0 .00;
more speech problems in oral and oropharyngeal cancer com-
pared to laryngeal/hypopharyngeal cancer). At time of





Mean age in years 64 (9.6, 43–83) (SD, range)
Tumor site




















Surgery and chemoradiation (other than
laryngectomy)
1 (2%)
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diagnosis (baseline), patient-reported speech outcomes were
significantly related to emotional distress (r0.25, p0 .04). At
follow-up, patient-reported speech outcomes were significant-
ly related to quality of life (r0−.49, p0 .00), emotional distress
(r0.53, p0 .00), and swallowing outcomes (r0.40, p0 .00).
Patient-reported swallowing outcome
At time of diagnosis, mean EORTC QLQ-H&N35 swallow-
ing subscale score was 19.03 (SD 25.2; range 0–83) and at
follow-up 26.87 (SD 29.2; range 0–92; Table 2). No swal-
lowing problems at baseline or follow-up were noted in
41 % of the patients. Nineteen percent had swallowing
problems at baseline and returned to normal scores at
follow-up, while 19 % had normal scores at baseline and
developed swallowing problems at follow-up; 21 % had
persistent problems from baseline to follow-up (Fig. 3).
Patient-reported swallowing outcomes were significantly
related to quality of life at the time of diagnosis (r0−.51,
p0 .00) and at follow-up (r0−.54, p0 .00), to emotional
distress at time of diagnosis (r0.52, p0 .00) and at follow-
up (r0.46, p0 .00), and to speech outcomes at follow-up
(r0.40, p0 .00). Swallowing reported outcomes were not
significantly related to gender, tumor site and stage, or
treatment modality.
Discussion
This explorative study evaluated computerized monitoring
of prospective patient-reported speech and swallowing
outcomes in an outpatient clinic through OncoQuest, a
touch screen computer system. A minority of the patients
reported speech (21 %) or swallowing problems (19 %) at
time of diagnosis, which is consistent with earlier studies
[21, 22]. In the present study, the majority either devel-
oped speech or swallowing problems after treatment (16
and 19 %, respectively) or had persistent speech or swal-
lowing problems from baseline to follow-up (40 and
21 %, respectively). In total, 56 % of the HNC patients
had speech problems and 40 % had swallowing problems
at first follow-up.
Table 2 Overview of mean scores and standard deviation (SD) on the
EORTC QLQ-C30 (global quality of life), EORTC QLQ-H&N35
(speech problems), EORTC QLQ-H&N35 (swallowing problems),
and HADS (distress) at baseline (at time of diagnosis) and first
follow-up (1 month after end of treatment)
Time of diagnosis First follow-up visit
Mean SD Mean SD
EORTC QLQ-C30 (global quality of life) 68.03 22.12 69.40 19.54
EORTC QLQ-H&N35 (speech problems) 22.72 26.27 29.52 25.54
EORTC QLQ-H&N35 (swallowing problems) 19.03 25.16 26.87 29.19
HADS (distress) 9.82 8.26 8.97 6.98
A higher mean score indicates a higher (i.e., more positive) level of functioning or global QOL. A higher mean score indicates a higher (i.e., more
negative) level of speech, swallowing problems, or distress symptoms
Fig. 2 Prospective speech problems (n067) Fig. 3 Prospective swallowing problems (n067)
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Previous studies of objective and subjective speech
and swallowing problems yielded similar results regard-
ing speech problems (ranging from 46 to 64 %) [23, 24],
and swallowing problems (ranging from 30 to 75 %) [23,
25]. Although prevalence rates vary significantly due to
methodological issues as inclusion criteria and assess-
ment methods, it is clear that a substantial part of HNC
patients report speech or swallowing problems before
and/or after treatment with a clear impact on quality of
life and emotional functioning. Also in earlier studies,
speech and swallowing problems in HNC patients
appeared to be significantly related to quality of life
and emotional well-being [26–31], as shown in the present
study. Structured monitoring of speech and swallowing
problems and quality of life in clinical practice appears to
be feasible, enhances patient–provider communication
[32], and may facilitate physicians to focus quickly on
issues that require further attention [10–12, 33] and to refer
patients (if indicated) to speech and swallowing rehabilita-
tion or other supportive care options in order to minimize
acute and late effects of HNC and its treatment and to
optimize quality of life.
In this study, two time points were chosen (before treat-
ment and shortly after end of treatment) to obtain insight in
acute side effects of treatment and possible needs for sup-
portive care at an early stage. All patients completed the
questionnaires at those time points. Longer follow-up will
provide more information on the course of speech and
swallowing problems. However, in clinical practice, it is
clear that the willingness to complete the questionnaires
drops over time. More long-term follow-up research is
needed to assess efficacy of structured monitoring of speech
and swallowing using a touch screen computer in clinical
practice and to investigate moderating factors that may
influence participation rate, such as age, gender, treatment
modality, and burden of symptoms.
Speech and swallowing function can be improved in
three ways. First, in planning surgery and (chemo-) radia-
tion, head and neck oncologists may take into account the
effects of their interventions on swallowing and speech
production by using intensity-modulated radiotherapy
to constrain the dose to be received by the swallowing
muscles [34] and to minimize the impact on surround-
ing healthy tissues [35]. Second, a number of rehabili-
tative procedures are available to reduce or eliminate
speech and swallowing problems after HNC surgery or
(chemo-) radiation [36–38] by performing range of mo-
tion exercises, resistance exercises, swallow maneuvers,
and compensation techniques. And third, speech and
swallowing may be evaluated before treatment to deter-
mine the speech and swallowing status at start and to
prepare the patient regarding possible speech and swal-
lowing impairments.
It remains unclear whether patients might benefit from
speech or swallowing rehabilitation (one of the main
reasons to monitor patient-reported speech and swallow-
ing outcome in the first place): efficacy studies of (pre-
treatment) speech and swallowing therapy are scarce
[39–42]. A pilot study in our clinic revealed that mobil-
ity and flexibility exercises during a burdensome period
of radiotherapy treatment are feasible. Exercises were
easily learned and carried out according to plan. The
protocol is extended with a DVD and a website (www.
halszaken-vumc.nl) as helpful e-health tools with infor-
mation, film clips with examples of the exercises, and e-
coaching. A prospective study is ongoing to investigate
the effectiveness of this exercise protocol during radiothera-
py. Next to effectiveness, this study will also provide insight
into determinants and barriers regarding participation and
compliance.
In the present study, the speech and swallowing sub-
scales of the EORTC QLQ-H&N35 module were used
to assess patient-reported speech and swallowing prob-
lems because they comprise only three speech and five
swallowing items, and are thus quick and easy to use in
a busy outpatient clinic. We used a cutoff score of 10
based on a cohort of 110 subjects from the general
population of whom 95 % scored below 10 on these
two subscales (unpublished data). However, these short
scales may not cover all speech- and swallowing-related
issues. The Speech Handicap Index (SHI) and the Swal-
lowing Questionnaire on Quality of Life (SWAL-QoL)
may provide more specific information on self-reported
speech and swallowing problems. The SHI was devel-
oped in a cohort of patients with oral or oropharyngeal
cancer [43] and consists of 30 items on speech prob-
lems in daily life. The SHI was validated and a cutoff
score of 6 (or higher) was defined on the total SHI
scale to identify patients with speech problems in daily
life after treatment for oral or oropharyngeal cancer,
which was confirmed in a recent study on laryngeal
cancer patients (unpublished data). In an earlier study,
we translated and validated the 44-item swallowing-
specific quality of life questionnaire SWAL-QoL and
defined a cutoff score of 14 points (or higher) regarding
the total SWAL-QOL score to identify patients with
swallowing problems after treatment for oral or oropha-
ryngeal cancer and [44]; this cutoff score was confirmed
in a recent study on laryngeal cancer patients (unpub-
lished data). Recently, based on the positive results of
the present study regarding the feasibility to monitor
speech and swallowing (as assessed by the short EORTC
QLQ-H&N35 scales) in clinical practice, the SWAL-QOL
and SHI have been built in OncoQuest. An ongoing research
focuses onwhether these longer questionnaires are also feasible
in clinical practice.
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Conclusion
Computerized monitoring of patient-reported speech and
swallowing outcome in a busy outpatient clinic using a
touch screen computer system (OncoQuest) is feasible.
Many HNC patients report speech and swallowing problems
before and after treatment, negatively affecting QoL and
emotional well-being.
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